Nanomix to Present at ``In3 East Medical Device Summit'' Conference, October 18-20, 2006, in Boston, MA
EMERYVILLE, Calif.--(BUSINESS WIRE)--Nanomix, Inc. (www.nano.com) was the first company to bring a nanoelectronic detection device to market and is aggressively pursuing commercialization of detection solutions for respiratory, life science, and industrial applications. Nanomix has developed an excellent intellectual property estate including over 65 patents.
As described in a recent article published in Proceedings of the National Academy of Science, Nanomix has established feasibility of nanoelectronic-based, label-free detection of DNA. This enables a wide variety of handheld, point-of-care tests for infectious disease, personalized medicine, and agricultural genetic detection.
Among the respiratory product applications, Nanomix is developing a respiratory monitor which is appropriate for hospital and pre-hospital settings, and has been optimized for Emergency Response personnel. This small, disposable device monitors varying CO2 levels. Clinical applications include endotracheal tube placement verification (critical in preventing brain damage and death from lack of oxygen), inter/intra hospital patient respiratory monitoring during transport, and monitoring the adequacy of CPR.
The commercialization of the Sensation™ detection platform creates a product portfolio that includes high-value detection solutions. David Macdonald, President and CEO of Nanomix, will be presenting a company overview and corporate strategy review on Thursday, October 19, 2006 at 3:55 PM EST, at Medtech Insight and Windhover Information's "In3 East Medical Device Summit" Conference at The Westin Hotel Copley Place in Boston, MA.
Nanomix is a leading nanoelectronic detection company launching a portfolio of devices based on Sensation™ technology. These scaleable devices use ultra-sensitive carbon nanotube detection elements combined with proprietary chemistries. They can be deployed across a broad range of industrial and medical applications where valuable attributes - low power consumption, small size, and high sensitivity offer significant performance advantages and enable unprecedented access to critical information. Nanomix is located in Emeryville, California. For additional information, please visit www.nano.com.